Exact Mass: 346.0851
Exact Mass Matches: 346.0851
Found 94 metabolites which its exact mass value is equals to given mass value 346.0851,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
ORYZALIN
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 3099 CONFIDENCE standard compound; INTERNAL_ID 2333 CONFIDENCE standard compound; INTERNAL_ID 8465
Methyl 6-O-galloyl-beta-D-glucopyranoside
Methyl 6-O-galloyl-beta-D-glucopyranoside is found in green vegetables. Tannin constituent of burnet bloodwort (Sanguisorba officinalis). Tannin constituent of burnet bloodwort (Sanguisorba officinalis). Methyl 6-O-galloyl-beta-D-glucopyranoside is found in green vegetables.
N1-(2-Hydroxyethyl)flurazepam
N1-(2-Hydroxyethyl)flurazepam is a metabolite of flurazepam. Flurazepam (marketed under the brand names Dalmane and Dalmadorm) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It produces a metabolite with a very long half-life (40–250 hours), which may stay in the bloodstream for up to four days. http://www. non-benzodiazepines. org. uk/equivalents. html Flurazepam is therefore unsuitable as a sleeping medication for some individuals due to next day sedation. (Wikipedia)
Hydroxydehydro Nifedipine Carboxylate
Raclopride
3,5-dichloro-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-6-methoxybenzamide
3-C-beta-D-glucopyranoside-2,4,6-trihydroxymethylbenzoate|methyl 3-C-beta,D-glucopyranoside-2,4,6-trihydroxybenzoate|ulmoside C
3alphaC-glucopyranosil-4,5-dihydroxy-2-methoxybenzoic acid
methyl 2-(beta-D-glucopyranosyloxy)-4,6-dihydroxybenzoate|methyl 2-O-beta-D-glucopyranosyl-2,4,6-trihydroxybenzoate
2,6-dihydroxy-5-methoxy-3-(1-C-(1-deoxy-beta-D-glucopyranosyl))benzoic acid
Raclopride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Raclopride is a dopamine D2/D3 receptor antagonist with potential antipsychotic effects. Raclopride binds to D2 and D3 receptors with Kis of 1.8 nM and 3.5 nM, respectively[1][2].
3,5-Pyridinedicarboxylic acid, 2-(hydroxymethyl)-6-methyl-4-(2-nitrophenyl)-, 5-methyl ester
Methyl 6-O-galloyl-b-D-glucopyranoside
(5R)-(+)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID
(5S)-(-)-2,2,3-TRIMETHYL-5-BENZYL-4-IMIDAZOLIDINONE DICHLOROACETIC ACID
2-ETHOXY-5-[(PIPERIDINE-1-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE
2,2-[1,2-Phenylenebis(oxy)]bis(1,3,2-benzodioxaborole)
Raclopride C 11
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
Sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate
4-(1H-benzimidazol-2-ylmethylsulfanyl)-2-methyl-[1]benzofuro[3,2-d]pyrimidine
1-[N-4-Nitrobenzyl-N-4-carboxybutylamino]methylphosphonic acid
3-[(1e,7e)-8-(2,6-Dioxo-1,2,3,6-Tetrahydropyrimidin-4-Yl)-3,6-Dioxa-2,7-Diazaocta-1,7-Dien-1-Yl]benzoic Acid
4-[(1e,7e)-8-(2,6-Dioxo-1,2,3,6-Tetrahydropyrimidin-4-Yl)-3,6-Dioxa-2,7-Diazaocta-1,7-Dien-1-Yl]benzoic Acid
(3e)-5-Fluoro-1-[(6-Fluoro-4h-1,3-Benzodioxin-8-Yl)methyl]-1h-Indole-2,3-Dione 3-Oxime
4-[(E)-[5-chloro-3-methyl-1-(4-methylphenyl)pyrazol-4-yl]methylideneamino]-3-methyl-1H-1,2,4-triazole-5-thione
7-chloro-5-(4-fluorophenyl)-4-(1-oxopropyl)-3,5-dihydro-1H-1,4-benzodiazepin-2-one
(2S,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3S,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenylazetidine-2-carbonitrile
(2R,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3R,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3R,4R)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2S,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
(2R,3S,4S)-1-(4-fluorophenyl)sulfonyl-4-(hydroxymethyl)-3-phenyl-2-azetidinecarbonitrile
Cephalexin(1-)
The anion resulting from the removal of a proton from the carboxylic acid group of cephalexin.
(2s)-6-hydroxy-4,7'-dimethyl-6'-oxaspiro[1-benzofuran-2,2'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),4',7',9',11'-pentaene-3,3'-dione
methyl 3,4-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoate
6-(4,5-dihydroxy-2-phenylnaphthalen-1-yl)-4-hydroxypyran-2-one
4-O-beta-D-Glucopyranosyl methyl gallate
{"Ingredient_id": "HBIN010747","Ingredient_name": "4-O-beta-D-Glucopyranosyl methyl gallate","Alias": "3,5-Dihydroxy-4-(beta-D-glucopyranosyloxy)benzoic acid methyl ester; methyl 3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-benzoate; methyl 3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate; 4-o-beta-d-glucopyranosyl methyl gallate; 4-o-\u03b2-d-glucopyranosyl methyl gallate; methyl 3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-benzoate; CHEMBL485255; 3,5-dihydroxy-4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]benzoic acid methyl ester; 3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-benzoic acid methyl ester; AC1NSVXX","Ingredient_formula": "C14H18O10","Ingredient_Smile": "COC(=O)C1=CC(=C(C(=C1)O)OC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "346.29 g/mol","OB_score": "17.35761295","CAS_id": "NA","SymMap_id": "SMIT06432;SMIT18930","TCMID_id": "25680;8681","TCMSP_id": "MOL004518","TCM_ID_id": "NA","PubChem_id": "5317705","DrugBank_id": "NA"}
bergenin monohydrate
{"Ingredient_id": "HBIN017922","Ingredient_name": "bergenin monohydrate ","Alias": "NA","Ingredient_formula": "C14H18O10","Ingredient_Smile": "COC1=C(C=C2C(=C1O)C3C(C(C(C(O3)CO)O)O)OC2=O)O.O","Ingredient_weight": "346.29 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19499","PubChem_id": "201412","DrugBank_id": "NA"}
